Rho GTPase regulation of α-synuclein and VMAT2: Implications for pathogenesis of Parkinson's disease
- 1 September 2011
- journal article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 48 (1) , 29-37
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Department of Veterans Affairs
This publication has 55 references indexed in Scilit:
- Serine 129 Phosphorylation Reduces the Ability of α-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2A in Vitro and in VivoJournal of Biological Chemistry, 2010
- Soluble Nogo Receptor Down-regulates Expression of Neuronal Nogo-A to Enhance Axonal RegenerationJournal of Biological Chemistry, 2010
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisNeuron, 2010
- Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 ratExperimental Neurology, 2009
- HSV-mediated Transfer of Artemin Overcomes Myelin Inhibition to Improve Outcome After Spinal Cord InjuryMolecular Therapy, 2009
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra NeuronsNeuron, 2009
- The effect of α‐synuclein knockdown on MPP+ toxicity in models of human neuronsEuropean Journal of Neuroscience, 2008
- GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synucleinProceedings of the National Academy of Sciences of the United States of America, 2008
- The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injuryExperimental Neurology, 2008
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005